Skip to main content
← All Vaccine Summaries Brought to you by the Open Source Medicine Foundation

Open Source Medicine Foundation

Vaccine pipeline 2026: candidates in clinical trials by company

Follow new and changed candidates: RSS feed (paste it into any feed reader).

Candidates in development — not yet (or no longer only) licensed products. Bulk rows are auto-grouped from a systematic ClinicalTrials.gov search (BIOLOGICAL interventions matching vaccine/vaccination), plus FDA CBER licensed/recent vaccine approvals (regulator-confirmed US status), and a small hand-curated set for filing edge cases. Filter by disease, developer, platform, and stage. Company-projected dates are labeled separately from regulator-confirmed status.

Data file: vaccine_pipeline_data.json · — · —

New

Upcoming vaccines: what is actually close

This table holds every candidate record, discontinued ones included. The upcoming view answers the narrower question: which applications a regulator's own published list says are under review, which registered trial readouts fall in the next two years by quarter, and which vaccines were licensed in the last two — with each date marked regulator-confirmed, company-announced or a registry estimate.

See what is close →

New

Progress and adoption outlook

Every candidate on one development ladder, its status in seven regulatory systems, and fast / typical / slow windows for licensing and a routine-use recommendation in the US, EU and Canada, built from published review targets and registry trial lengths. Each candidate page now carries its own outlook block.

Open the outlook →

ⓘ How to read this dashboard

Pipeline status reflects the most recent publicly available company and regulatory disclosures as of the date shown per candidate — not a guarantee of approval or timeline. Most vaccine candidates that enter clinical trials do not reach licensure; company-projected timelines frequently shift. Status is cross-checked against public regulatory sources where possible, but company-reported milestones (trial starts, filing announcements) are the company's own claims pending independent confirmation. Orange = company estimate; Green = regulator-confirmed framing.

✓

Dedicated Candidate Page Inclusion Threshold

While the dashboard lists all active research programs identified in clinical registry databases, full standalone reference pages (pipeline/.html) are generated specifically for candidates that have achieved at least one of the following high-readiness development criteria:

  • 1 Active Phase 3 clinical evaluation
  • 2 Formal BLA / MAA regulatory submission filed
  • 3 Approved in ≥1 major tier-1 jurisdiction (US, EU, CA, AU)
⚡

Recent Pipeline Milestones & Delta Feed

Live tracker of regulatory approvals, Phase transitions, and trial completion updates across candidates

147 Tracked Milestones
View:
Candidate Developer Disease Platform Stage Next milestone Verified

Candidate details

Click a table or kanban row to load jurisdiction status, trials, and sources here (avoids freezing the browser with hundreds of open cards).

Select a candidate from the table above.

Vaccine candidates by company

222 candidates with a dedicated page, grouped by developer and sorted by stage. The interactive table above has every tracked record, including stopped trials.

GSK (27)
FDA-licensed products (manufacturer per FDA listing) (26)
Moderna (20)
Sinovac (20)
Sanofi (18)
Pfizer (15)
BioNTech (10)
CanSino (9)
Merck (MSD) (9)
Serum Institute of India (5)
Bavarian Nordic (4)
Vaxcyte (4)
Emory University (3)
Valneva (3)
Other developers (49)

Sources & update cadence

Download JSON data · Schema: vaccine_pipeline.schema.json

More vaccines in the regulatory pipeline

Part of the Open Source Medicine Foundation Network

Open Source Medicine Foundation

Home of the OSMF network — open-source pharmacovigilance tools and evidence-based medicine resources.

Research Tracker

Track peer-reviewed literature on vaccine safety, pharmacovigilance, and post-market surveillance.

Evidence Desk

Soft launch — provisional claim grades; not medical advice. Does not contain vaccine lot or VAERS data.

SpikeProtein.site

Comprehensive resource on spike protein biology, biodistribution, and clinical implications.

VitalScan4PACVS

Decentralized trial for PACVS (post-acute COVID-19 vaccination syndrome).

PACVS Research Summit

Weekly seminar series for researchers and clinicians studying post-acute COVID-19 vaccination syndrome.